B
3.68
0.08 (2.22%)
| 前收盘价格 | 3.60 |
| 收盘价格 | 3.62 |
| 成交量 | 97,056 |
| 平均成交量 (3个月) | 401,710 |
| 市值 | 257,573,776 |
| 价格/销量 (P/S) | 4.09 |
| 股市价格/股市净资产 (P/B) | 0.490 |
| 52周波幅 | |
| 利润日期 | 29 Oct 2026 |
| 营业利益率 (TTM) | -703.66% |
| 稀释每股收益 (EPS TTM) | -3.16 |
| 季度收入增长率 (YOY) | -48.90% |
| 总债务/股东权益 (D/E MRQ) | 1.12% |
| 流动比率 (MRQ) | 14.86 |
| 营业现金流 (OCF TTM) | -180.22 M |
| 杠杆自由现金流 (LFCF TTM) | -108.88 M |
| 资产报酬率 (ROA TTM) | -21.69% |
| 股东权益报酬率 (ROE TTM) | -37.07% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Bicycle Therapeutics plc | 混合的 | 看跌 |
AIStockmoo 评分
-1.5
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -2.5 |
| 相对估值 | NA |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | -1.50 |
|
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 1.46% |
| 机构持股比例 | 93.44% |
该时间范围内无数据。
该时间范围内无数据。
AI 技术分析
打开“技术”标签以生成最新分析。
投资组合